The American Society of Clinical Oncology (ASCO) 2020 Virtual Annual Meeting was full of exciting updates in the treatment and management of patients with lung cancer, including data from the ADAURA, CITYSCAPE, LIBRETTO-001 and RESILIENT studies.
Roy Herbst
ADAURA: osimertinib post-tumor resection in NSCLC
Melissa Johnson
CITYSCAPE: tiragolumab in NSCLC
Vivek Subbiah
Intracranial activity of selpercatinib in RET fusion positive NSCLC
